|
|
|
Volumn , Issue 315, 2010, Pages 39-45
|
|
Intravitreal bevacizumab for myopic choroidal neovascularization: 1-year and 2-year results.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
ADULT;
AGED;
ARTICLE;
FEMALE;
FOLLOW UP;
HUMAN;
INTRAVITREAL DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
MYOPIA;
RETROSPECTIVE STUDY;
SUBRETINAL NEOVASCULARIZATION;
TREATMENT OUTCOME;
VISUAL ACUITY;
ADULT;
AGED;
AGED, 80 AND OVER;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
CHOROIDAL NEOVASCULARIZATION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INTRAVITREAL INJECTIONS;
MALE;
MIDDLE AGED;
MYOPIA;
RETROSPECTIVE STUDIES;
TREATMENT OUTCOME;
VISUAL ACUITY;
|
|
EID: 79952113659
PISSN: 00810746
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
